From Pharma To Biopharma — Education & Workforce Training Programs Converge To Meet Industry Needs
June 9, 2021
In 1982, when the FDA approved the first recombinant drug (insulin), there was a clear line between pharmaceutical companies and, as they were called at the time, biotechnology companies. That line has faded into history, with the convergence of the biopharmaceutical industry.
Be the first to know about new Contract Services and Workforce Training programs and all the latest info on how the Stack Family Center for Biopharmaceutical Education and Training is powering the careers of students and the future workforce needs of biotech companies.